Literature DB >> 18093245

Leukaemic dissemination of Merkel cell carcinoma in a patient with systemic lupus erythematosus.

I Nemoto1, K C Sato-Matsumura, Y Fujita, K Natsuga, H Ujiie, Y Tomita, N Kato, M Kondo, K Ohnishi.   

Abstract

We describe an unusual bone-marrow metastasis of Merkel cell carcinoma (MCC) arising in the right cheek of a 73-year-old woman with systemic lupus erythematosus (SLE) and Sjögren's syndrome, who had been treated with oral prednisolone and methotrexate for 10 years. Seven months after wide local excision followed by local irradiation, the patient presented with thrombocytopaenia. Her bone marrow had been completely replaced by metastatic MCC cells, and metastatic cytokeratin 20-positive cells were also identified in the peripheral blood. To our knowledge, in the English literature, only six cases have been described previously of MCC bone-marrow involvement. Of these six cases, four were immunosuppressed, similar to our case. The high incidence of MCC in immunosuppressed patients such as those with SLE has been discussed previously. We consider that immunosuppression might be associated with bone-marrow metastasis, which is a rare form of MCC.

Entities:  

Mesh:

Year:  2007        PMID: 18093245     DOI: 10.1111/j.1365-2230.2007.02618.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

Review 1.  Metastatic Merkel cell carcinoma in the bone marrow of a patient with plasma cell myeloma and therapy-related myelodysplastic syndrome.

Authors:  Megan Kielt Kressin; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

2.  Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.

Authors:  Astrid Blom; Shailender Bhatia; Stephanie Pietromonaco; Karen Koehler; Jayasri G Iyer; Kotaro Nagase; Kelly Paulson; Daniel E Sabath; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2013-12-31       Impact factor: 11.527

3.  Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.

Authors:  Maria Rita Gaiser; Kenneth Daily; Jochen Hoffmann; Maik Brune; Alexander Enk; Isaac Brownell
Journal:  Oncotarget       Date:  2015-09-22

Review 4.  Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

Authors:  Cillian F De Gascun; Michael J Carr
Journal:  Clin Dev Immunol       Date:  2013-05-02

5.  Merkel cell carcinoma in immunosuppressed patients.

Authors:  Janice E Ma; Jerry D Brewer
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.